Browsing by Author "Jelínková, Sandra"
Now showing items 1-1 of 1
-
Vliv vandetanibu, lenvatinibu a ellipticinu na expresi potkaních cytochromů P450 1A a 3A
Defence status: DEFENDEDJelínková, Sandra (Univerzita Karlova, Přírodovědecká fakulta, 2018)Date of defense: 21. 5. 2018In recent years, the inhibiition of tyrosine kinases,which may incorrectly regulate some singaling pathway has been used to treat cancer as so-called biological therapy. An example of such inhibitors are vandetanib and ...